trial

Switching From Consta® to Sustenna® in Patients With Schizophrenia

NCTId NCT01698216
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 50 (actual)
Sponsored by Seoul National University Hospital
Primary completion 2015-05
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
50 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2011-12
Primary completion
2015-05
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
—

Sponsors

Seoul National University HospitalLead Sponsor

Investigators

1
Yong Min Ahn, MD, PhDPrincipal Investigator

Sites

1 total
Seoul, South Korea

Facts & assertions

4 sourced
Enrollment
50
Phase
NA
Primary Completion Date
2015-05
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
Seoul National University Hospital
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Yong Min Ahn, MD, PhD
person